Nutriband Inc. (NASDAQ:NTRBW – Get Free Report)’s share price shot up 7.6% during mid-day trading on Wednesday . The company traded as high as $1.70 and last traded at $1.70. 200 shares traded hands during trading, a decline of 98% from the average session volume of 11,481 shares. The stock had previously closed at $1.58.
Nutriband Stock Performance
The business’s 50 day simple moving average is $1.68 and its 200-day simple moving average is $1.78.
Institutional Inflows and Outflows
An institutional investor recently raised its position in Nutriband stock. Citadel Advisors LLC increased its stake in Nutriband Inc. (NASDAQ:NTRBW – Free Report) by 8.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 126,392 shares of the company’s stock after acquiring an additional 9,801 shares during the period. Citadel Advisors LLC’s holdings in Nutriband were worth $190,000 at the end of the most recent reporting period.
Nutriband Company Profile
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.
See Also
- Five stocks we like better than Nutriband
- Best Stocks Under $5.00
- $30B AI Opportunity: Will It Power Meta’s Next Surge?
- Consumer Discretionary Stocks Explained
- Microsoft Could Rally as EU Antitrust Case Nears Resolution
- Why is the Ex-Dividend Date Significant to Investors?
- Intel Refocuses: NEX Sale and Foundry Pivot Signal New Era
Receive News & Ratings for Nutriband Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutriband and related companies with MarketBeat.com's FREE daily email newsletter.
